TerminatedPHASE1, PHASE2NCT02815540
The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy
Studying Lennox-Gastaut syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gillette Children's Specialty Healthcare
- Principal Investigator
- Beverly S Wical, MDGillette Children's Specialty Healthcare
- Intervention
- 12-Lead ECG(procedure)
- Enrollment
- 2 enrolled
- Eligibility
- 2-30 years · All sexes
- Timeline
- 2017 – 2018
Study locations (1)
- Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02815540 on ClinicalTrials.govOther trials for Lennox-Gastaut syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06924086The Children's Adaptive Deep Brain Stimulation for Epilepsy TrialUniversity College, London
- RECRUITINGPHASE3NCT05066217An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut SyndromeEpygenix
- RECRUITINGNCT05485831Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALYJazz Pharmaceuticals
- ACTIVE NOT RECRUITINGNANCT06464653Pallidothalamic Tracts Electrical Stimulation for Lennox-Gastaut SyndromeLiankun_Ren
- RECRUITINGNCT05374824Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut SyndromeAnn & Robert H Lurie Children's Hospital of Chicago
- ACTIVE NOT RECRUITINGPHASE4NCT05044819Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral SolutionJazz Pharmaceuticals